GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Sandoz.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Sandoz
ClinicalTrials.gov Identifier:
NCT01274182
First received: January 10, 2011
Last updated: November 11, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)